Literature DB >> 27248789

Transitions of care in the management of acute bacterial skin and skin structure infections: a paradigm shift.

Jaime E Verastegui1, Yukihiro Hamada1, David P Nicolau2.   

Abstract

Acute bacterial skin and skin structure infections (ABSSSI) have evolved over a relatively short period of time to become one of the most challenging medical problems encountered in clinical practice. Notably the high incidence of methicillin-resistant S. aureus (MRSA) across the continuum of care has coincided with increased outpatient failures and higher rates of hospital admissions for parental antibiotic therapy. Consequently the management of ABSSSI constitutes a tremendous burden to the healthcare system in terms of cost of care and consumption of institutional and clinical resources. This perspective piece discusses current and new approaches to the management of ABSSSI in a hospital setting and the need for a multifaceted approach. Treatment strategies for the management through the utilization of observation units (OU), Outpatient Parental Antibiotic Therapy (OPAT), and newly developed antibiotics for the use against skin infections caused by Gram-positive bacteria will be discussed in the context of ABSSSI.

Entities:  

Keywords:  ABSSSI; Transitions of care; dalbavancin; observational units; oritavancin; tedizolid

Mesh:

Substances:

Year:  2016        PMID: 27248789     DOI: 10.1080/17512433.2016.1195683

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  9 in total

Review 1.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

2.  Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections.

Authors:  David P Nicolau; Barry N Silberg
Journal:  Infect Drug Resist       Date:  2017-07-26       Impact factor: 4.003

3.  Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: Results of a network meta-analysis.

Authors:  Julian F Guest; Jaime Esteban; Anton G Manganelli; Andrea Novelli; Giuliano Rizzardini; Miquel Serra
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

4.  Variability in Emergency Medicine Provider Decisions on Hospital Admission and Antibiotic Treatment in a Survey Study for Acute Bacterial Skin and Skin Structure Infections: Opportunities for Antimicrobial Stewardship Education.

Authors:  Safa S Almarzoky Abuhussain; Michelle A Burak; Danyel K Adams; Kelsey N Kohman; Serina B Tart; Athena L V Hobbs; Gabrielle Jacknin; Michael D Nailor; Katelyn R Keyloun; David P Nicolau; Joseph L Kuti
Journal:  Open Forum Infect Dis       Date:  2018-10-08       Impact factor: 3.835

5.  Impact of Outpatient vs Inpatient ABSSSI Treatment on Outcomes: A Retrospective Observational Analysis of Medical Charts Across US Emergency Departments.

Authors:  P Brandon Bookstaver; Timothy C Jenkins; Edward Stenehjem; Shira Doron; Jack Brown; Shannon H Goldwater; Carlos Lopes; Angela Haynes; Chuka Udeze; Yifan Mo; Patrick Gillard; Yan Liu; Katelyn Keyloun
Journal:  Open Forum Infect Dis       Date:  2018-05-15       Impact factor: 3.835

6.  Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department.

Authors:  Safa S Almarzoky Abuhussain; Michelle A Burak; Kelsey N Kohman; Gabrielle Jacknin; Serina B Tart; Athena L V Hobbs; Danyel K Adams; Michael D Nailor; Katelyn R Keyloun; David P Nicolau; Joseph L Kuti
Journal:  BMC Health Serv Res       Date:  2018-12-04       Impact factor: 2.655

7.  Omadacycline for Acute Bacterial Skin and Skin Structure Infections.

Authors:  Fredrick M Abrahamian; George Sakoulas; Evan Tzanis; Amy Manley; Judith Steenbergen; Anita F Das; Paul B Eckburg; Paul C McGovern
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

8.  Omadacycline: A Modernized Tetracycline.

Authors:  Jason C Gallagher
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

9.  Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012.

Authors:  Khine Tun; James F Shurko; Laurajo Ryan; Grace C Lee
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.